EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Treatment-resistant depression: Current therapeutic strategies

Samuel Cândido Freres, Marco Antonio Franco Cançado, Aline Ferreira Catrolio, Vanderli Barbosa Amaecing, Rodolfo Nunes Mendes Da Cunha, Sharie Lohanna de Moraes Nascimento

International Health Sciences Review · 18.08.2026 · 2 (4)

DOI: 10.70164/ihsr.v2i4.208 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Health Sciences Review, online erschienen am 18.08.2026. Verfasst von Samuel Cândido Freres und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Treatment-resistant depression (TRD) represents one of the most complex forms of major depressive disorder, characterized by the persistence of clinically significant symptoms despite the performance of appropriate therapeutic interventions. This condition is associated with a worse prognosis, higher risk of recurrence, functional impairment, increased morbidity and mortality, and high socioeconomic impact. The objective of this article was to review the main aspects related to ESRD, addressing its definition, diagnostic criteria, epidemiology, pathophysiological mechanisms, and currently available therapeutic strategies. A narrative review of the literature was carried out, including national and international studies that discuss advances in the management of resistant depression. It is observed that the pathophysiology of ESRD involves alterations in mon oaminergic and glutamatergic neurotransmission, reduced neuroplasticity, inflammatory processes, neuroendocrine dysfunctions, and genetic factors, justifying the limited efficacy of conventional antidepressants in some patients. Current therapeutic strategies include optimization and combination of antidepressants, pharmacological potentiation, use of atypical antipsychotics, lithium, and thyroid hormones, as well as innovative therapies such as ketamine and esketamine, which demonstrate rapid antidepressant response in selected cases. It is concluded that the management of ESRD should be individualized, based on up-to-date scientific evidence, and integrated with multidisciplinary approaches, aiming at symptom remission, functional recovery, and improvement of patients' quality of life.

Zitieren

APA

Freres, S. C., Cançado, M. A. F., Catrolio, A. F., Amaecing, V. B., Cunha, R. N. M. D., & Nascimento, S. L. D. M. (2026). Treatment-resistant depression: Current therapeutic strategies. International Health Sciences Review, 2(4). https://doi.org/10.70164/ihsr.v2i4.208

Vancouver

Freres SC, Cançado MAF, Catrolio AF, Amaecing VB, Cunha RNMD, Nascimento SLDM. Treatment-resistant depression: Current therapeutic strategies. International Health Sciences Review. 2026;2(4). doi:10.70164/ihsr.v2i4.208

BibTeX
@article{Freres2026,
  author = {Freres, Samuel Cândido and Cançado, Marco Antonio Franco and Catrolio, Aline Ferreira and Amaecing, Vanderli Barbosa and Cunha, Rodolfo Nunes Mendes Da and Nascimento, Sharie Lohanna de Moraes},
  title = {Treatment-resistant depression: Current therapeutic strategies},
  journal = {International Health Sciences Review},
  year = {2026},
  volume = {2},
  number = {4},
  doi = {10.70164/ihsr.v2i4.208}
}
Kostenlos starten →